Pecani, M.; Andreozzi, P.; Cangemi, R.; Corica, B.; Miglionico, M.; Romiti, G.F.; Stefanini, L.; Raparelli, V.; Basili, S.
Metabolic Syndrome and Liver Disease: Re-Appraisal of Screening, Diagnosis, and Treatment Through the Paradigm Shift from NAFLD to MASLD. J. Clin. Med. 2025, 14, 2750.
https://doi.org/10.3390/jcm14082750
AMA Style
Pecani M, Andreozzi P, Cangemi R, Corica B, Miglionico M, Romiti GF, Stefanini L, Raparelli V, Basili S.
Metabolic Syndrome and Liver Disease: Re-Appraisal of Screening, Diagnosis, and Treatment Through the Paradigm Shift from NAFLD to MASLD. Journal of Clinical Medicine. 2025; 14(8):2750.
https://doi.org/10.3390/jcm14082750
Chicago/Turabian Style
Pecani, Marin, Paola Andreozzi, Roberto Cangemi, Bernadette Corica, Marzia Miglionico, Giulio Francesco Romiti, Lucia Stefanini, Valeria Raparelli, and Stefania Basili.
2025. "Metabolic Syndrome and Liver Disease: Re-Appraisal of Screening, Diagnosis, and Treatment Through the Paradigm Shift from NAFLD to MASLD" Journal of Clinical Medicine 14, no. 8: 2750.
https://doi.org/10.3390/jcm14082750
APA Style
Pecani, M., Andreozzi, P., Cangemi, R., Corica, B., Miglionico, M., Romiti, G. F., Stefanini, L., Raparelli, V., & Basili, S.
(2025). Metabolic Syndrome and Liver Disease: Re-Appraisal of Screening, Diagnosis, and Treatment Through the Paradigm Shift from NAFLD to MASLD. Journal of Clinical Medicine, 14(8), 2750.
https://doi.org/10.3390/jcm14082750
